No more than 15 authors can be listed.Please ensure the authors are listed in the right order.If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.
Respiratory infections caused by antimicrobial-resistant pathogens are a major driver of global mortality, with air pollution acting as a potential vector for inhaled antimicrobial resistance genes (ARGs). However, the role of air pollution in driving antibiotic resistance in respiratory pathogens remains poorly understood, particularly in low- and middle-income countries (LMICs). We conducted a longitudinal study across 31 countries in six global regions (Asia, Africa, the Middle East, the Pacific Islands, and Latin America) to assess respiratory exposure risks from air-borne ARGs.
Between 2018 and 2025, approximately 44 000 ambient air samples were collected quarterly in major cities across 31 countries. Samples were analysed using metagenomics to detect ~200 antimicrobial resistance genes and key respiratory pathogens. ARG profiles were integrated with country-level data on air pollution, respiratory disease burden, antibiotic consumption, sanitation, socioeconomic indicators, climate, population, and year.
Airborne ARG prevalence increased significantly over time and was consistently associated with air pollution, particularly PM₂.₅, and respiratory disease burden across all countries. Higher airborne ARG burdens were observed in Thailand, India, Pakistan, Myanmar, Vietnam, Indonesia, Syria, Haiti, Iraq, and Libya. Clinically important ARGs linked to respiratory infections (blaNDM-1, mcr-1, mecA, vanA) were detected in approximately 80% of samples. The prevalence of major respiratory bacterial pathogens, including Pseudomonas spp., Klebsiella pneumoniae, Staphylococcus aureus, Acinetobacter baumannii, Mycoplasma pneumoniae, and Streptococcus pneumoniae, in ambient air increased significantly over time. Multivariable analyses showed that respiratory disease burden, antibiotic use, climate, and population characteristics were independently associated with higher airborne ARG abundance (r > 0.8, p < 0.001).
Our study provides the first global evidence that ambient air pollution is an under-recognised pathway for respiratory exposure to antimicrobial resistance in low- and middle-income countries, highlighting the need to integrate air quality management with antimicrobial resistance control and respiratory disease prevention.